Back to BAILLIE GIFFORD & CO BAILLIE GIFFORD & CO

VIRVIR

Showing 2 of 21 quarters

Position history for BAILLIE GIFFORD & COBAILLIE GIFFORD & CO's holdings in VIR BIOTECHNOLOGY INC

No. Baillie Gifford exited its VIR (Vir Biotechnology) position in Q4 2024. Its Q3 2024 13F listed 2,383,029 shares worth $17.8M. Baillie Gifford already held VIR in its Q4 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$17.8M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$7.33
0
2024-Q3
Decreased
2.4M
-39.2%
$17.8M0.0%$7.53
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used